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Abstract 
Background: Gunnera tinctoria has been collected by Mapuche‑Pewenche people for food and medicinal purposes. 
The high polyphenol content of methanolic extract from G. tinctoria leaves with chemical constituents such as ellagic 
acid and quercetin derivatives suggests its application to prevent endothelial dysfunction and oxidative stress. The 
aim of this study was to provide evidence of the protective effect of this extract on endothelial function by reduc‑
ing oxidative stress induced by high d‑glucose and  H2O2, as well as by stimulating nitric oxide (NO) levels in human 
umbilical vein endothelial cells (HUVECs).
Results: A methanolic extract with a high content of polyphenols (520 ± 30 mg gallic acid equivalents/g dry extract) 
was obtained from G. tinctoria leaves. Its main constituent was ellagic acid. The results of Ferric reducing antioxidant 
power and 2,2‑diphenyl‑1‑picrylhydrazyl radical scavenging assays of the extract confirmed its antioxidant activity by 
inhibition pathway of radical species. The incubation of HUVECs with the extract decreased the apoptosis and reactive 
oxygen species (ROS) synthesis induced by high extracellular concentration of d‑glucose or hydrogen peroxide. The 
extract increased endothelial NO levels and reduced vasoconstriction in human placental vessels.
Conclusions: This study provides evidence about the antioxidant and endothelial protective properties of metha‑
nolic G. tinctoria leaf extract. The extract improves the availability of NO in HUVECs, inhibiting the production of ROS 
and vasoconstriction.
Keywords: Gunnera tinctoria, Methanolic extract, Endothelial function, Antioxidant activity
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
The collection of wild plants for medicinal purposes is an 
ancient tradition that has endured in the Mapuche com-
munity. Gunnera tinctoria (Molina) Mirb., which belongs 
to Gunnera genus, is widely distributed in South America 
and has been collected by Mapuche-Pewenche people for 
food and medicinal purposes. Thus, decocts of leaves, 
petioles or roots were prepared to assist in the treatment 
of dysentery [1]. Estomba et al. [2] suggested that G. tinc-
toria may have beneficial effects in curing urinary, high 
respiratory tract and circulatory diseases. Petioles and 
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roots are also used against uterus pains, ulcer and liver 
injuries, as well as an hemostatic and anti-inflammatory 
remedy [3]. Zamorano et  al. [4] reported that dehy-
drated G. tinctoria leaves have antioxidant capacity and 
antifungal activity against Cryptococcus laurentii. They 
attributed the biological activity to the high content of 
polyphenols in the leaves of G. tinctoria, where catechin 
and epicatechin were the main polyphenol constituents 
found. These flavonoids were also identified as major 
compounds in ethanolic extracts of G. tinctoria leaves 
[5].
In prior studies, we found that methanolic extracts of 
G. tinctoria show dermal anti-inflammatory activity for 
edema in mouse ear induced by 12-O-tetradecanoyl-
phorbol-13 acetate [6] and arachidonic acid [7]. This 
pharmacological activity was attributed to the pres-
ence of polyphenols such as ellagic acid [8] and querce-
tin derivatives [9]. In particular, ellagic acid prevents 
the oxidized low-density lipoprotein (oxLDL)-induced 
reactive oxygen species (ROS) in human umbilical vein 
endothelial cells (HUVECs) [10] and inhibits NF-kappa 
B activity, a transcription factor involved in increasing 
the pro-inflammatory response [11, 12]. Based on the 
chemical constituents of G. tinctoria extracts, we suggest 
that its application may be beneficial in the prevention 
of endothelial dysfunction due to oxidative stress and 
inflammation.
Endothelial function is closely related to endothelium-
derived nitric oxide (NO), a signaling molecule that 
induces relaxation in vascular smooth muscle cells, lead-
ing to reduction of vascular resistance and physiologi-
cal regulation of mean arterial pressure [13, 14]. Natural 
nutritional products can improve endothelial function. 
However, relatively limited information is available about 
the active ingredients of food products, their bioavailabil-
ity and cellular targets [15, 16].
Effective herbal drugs for treatment of endothelial dys-
function should be able to improve NO synthesis and 
reduce ROS synthesis and apoptosis induced by delete-
rious agents such as high concentration of d-glucose or 
hydrogen peroxide [17, 18].
HUVECs are a primary culture commonly used as an 
in vitro model to evaluate the effect of plant extracts on 
endothelial function. The antioxidative and antiglycative 
effects of the aqueous extract of Psidium guajava L. on 
endothelial cells exposed to glucose, glyoxal and methyl-
glyoxal were studied using the HUVEC model [19]. The 
authors found that the polyphenolic compounds in the 
extract were potent ROS inhibitors, capable of block-
ing protein glycation, and had an antiapoptotic effect. 
Recently, it has been determined that icariin, a flavonoid 
glycoside isolated from the plant species Epimedium, 
can protect against high d-glucose-induced endothelial 
dysfunction in  vitro, through attenuation of apopto-
sis, oxidative stress, and inflammation [18]. In general, 
HUVECs are considered a reliable and simple in  vitro 
model for predicting and understanding the biological 
response of endothelial cells to plant extracts.
Based on the above-mentioned background, we postu-
late that the methanolic extract of G. tinctoria attenuates 
apoptosis and ROS generation induced by high d-glu-
cose and  H2O2, as well as stimulates NO synthesis in 
HUVECs, which improves endothelial function. We used 
two pathways to induce oxidative stress on HUVECs, 
exogenous supplementation of  H2O2 (direct pathway) 
and high-D glucose [20]. In cultured HUVECs, high 
D-glucose increases the synthesis of superoxide through 
activation of nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase [17]. The aim of this study is to 
provide evidence about the protective effect of G. tincto-
ria extract on endothelial function by reducing oxidative 
stress induced by high d-glucose and  H2O2 as well as by 
the stimulation of NO levels in HUVECs. The chemical 
constituents of methanolic G. tinctoria extracts are iden-




Leaves of G. tinctoria Mol. (Nalca) were collected in 
April 2012 in the Araucanía Region of Chile. Leaves were 
air-dried, knife grounded and sieved up to a particle size 
of 500 µm. The voucher material was deposited at Her-
barium of Pharmacy School, Universidad Andres Bello 
(Collection number HPS-UNAB/14024).
Preparation of the methanolic extract from G. tinctoria 
leaves
The methanolic extract was obtained by successive mac-
eration of 100 g of dried plant material (average particle 
size < 500 µm) with hexane, dichloromethane, ethyl ace-
tate, and methanol, at room temperature for 48  h. The 
solid residue/solvent ratio was 1/10 (w/v). The disper-
sion was continually stirred at 800 rpm. Finally, the crude 
extracts were concentrated under reduced pressure to 
dryness.
Polyphenol content
The quantification of polyphenols was done according 
to the Folin–Ciocalteau method with modifications [21]. 
The phenolic content was expressed as mg gallic acid 
equivalents/g dry methanolic extract (mg GAE/g extract). 
The measurements were made in triplicate.
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Fractionation of G. tinctoria extract by pH‑zone refinement 
using centrifugal partition chromatography (CPC)
The extract of G. tinctoria was fractionated using a Spot-
CPC-250-B Bio-Extractor (CPC, Armen, France). The 
system had a four-way switching valve that allowed oper-
ation in either descending or ascending modes. The CPC 
unit was connected to a SPOT.PREP II system (Armen, 
France), with integrated UV detector and fraction collec-
tor. CPC separation was performed using the pH zone 
refinement method described by Ref. [22] with slight 
modifications. The two-phase solvent system was com-
posed of methyl tert-butyl ether/1-butanol/acetonitrile/
water with a volume ratio of 4:2:3:8. The solvent mixture 
was equilibrated in a separation funnel and divided in an 
upper and lower phase, where 10 mM trifluoroacetic acid 
(TFA) was added as a retainer to the upper organic phase 
and 10  mM  NH3 was added as a displacer to the lower 
phase. The CPC rotor was first filled with 1.5 column vol-
umes using the upper phase at 30 mL/min and 500 rpm 
rotation. The lower phase was pumped into the system 
(descending mode) at a flow rate of 12 mL/min and rota-
tion was increased from 500 to 2000  rpm. The samples 
(1 g of G. tinctoria extract) were dissolved in 10 mL 1:1 
mixture of upper (with 10  mM TFA) and lower (with-
out  NH3) layers and injected into the CPC system at the 
same time the lower phase was introduced. Elution was 
monitored using a scan in the range of 200–600 nm; and 
at 254 and 360 nm wavelengths, by collecting fractions in 
32 mL tubes. Fractions with similar concentrations were 
combined according to on-line UV spectra and thin layer 
chromatography results.
Liquid chromatography parameters and MS parameters
Fast preliminary analysis of the G. tinctoria extract was 
performed using a RP-HPLC–UV with a monolithic RP-
18e column Chromolith 100–10 mm (Merck, Germany). 
The mobile phases employed were (A) water with 0.1% 
TFA and (B) acetonitrile while the gradient program 
was: (0.00  min, 0% B); (10.00  min, 20% B); (12.00  min, 
20% B); (14.00  min, 0% B) and 2  min for column equi-
libration before injections. The flow rate employed 
was 5.00  mL/min, and the injection volume was 50  μL. 
Liquid chromatography-mass spectrometry was per-
formed using an Acclaim UHPLC C18 column (Acclaim, 
150  mm × 4.6  mm internal diameter, 2.5  μm, Thermo 
Fisher Scientific, Bremen, Germany) set at 25  °C. The 
wavelengths used for detection were 354, 254, 280, and 
330 nm, and DAD was acquired from 200 to 800 nm for 
full characterization of peaks. Mobile phases employed 
were acetonitrile (B) and 1% aqueous formic solution 
(A) while the gradient program was: (0.00  min, 7% B); 
(5.00  min, 7% B); (10.00  min, 25% B); (15.00  min, 33% 
B); (20.00  min, 85% B); (25.00  min, 90% B); (35.00  min, 
7% B) and 15 min for column equilibration before injec-
tions. The flow rate employed was 1.00 mL/min, and the 
injection volume was 10  μL. Standards and the extract 
dissolved in methanol were maintained at 10  °C during 
storage in the auto-sampler. The HESI II and Orbitrap 
spectrometer parameters were set as informed previously 
[23]. Peak identification was done analyzing the mass 
spectra, fragmentation patterns and by comparison with 
pure standards, accordingly.
In vitro antioxidant activity of G. tinctoria extract
Ferric reducing antioxidant power (FRAP)
In vitro antioxidant activity of G. tinctoria extract was 
determined using the FRAP assay with modifications 
[24]. The FRAP reagent was prepared mixing 1020 µL of 
sodium acetate 300 mM at pH 3.6, 100 µL of 2,4,6-tripy-
ridyl-s-triazine 10  mM, and 100 µL of  FeCl3·6H2O 
20 mM. Then, 10 µL of extract dissolution was added to 
the FRAP reagent. The calibration curve was prepared 
with  FeSO4 solution in concentrations ranging from 15 to 
35 µM and using the FRAP reagent as blank. The absorb-
ance was measured at 593 nm in a Jenway 6405 UV–Vis 
spectrophometer, after 4 and 60 min of heating at 40 °C. 
The average of three measurements were expressed as 
µmol  Fe2+/g dry methanolic extract. Quercetin was used 
as reference compound. Ferric reducing antioxidant 
power values of G. tinctoria extract and quercetin at 4 
and 60 min were reported.
2,2‑diphenyl‑1‑picrylhydrazyl (DPPH) radical scavenging 
activity
The method is based on the decrease of absorbance of 
DPPH dissolved in methanol when mixed with an antiox-
idant compound. The decrease in absorbance at 515 nm 
is inversely proportional to the antioxidant activity. An 
aliquot of 100 µL of G. tinctoria extract were added to 
3.9  mL of DPPH methanolic solution (25  mg/L). The 
absorbance at 515  nm was recorded at the beginning 
 (Absorbanceonset) and in steady state  (Absorbanceend) at 
room temperature, and the remnant DPPH was calcu-
lated as follows:
The antiradical efficiency (AE) was expressed as [25]:
where  EC50 is the concentration of antioxidant required 
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50% and is obtained from a curve of remnant DPPH % 
versus extract concentration.  TEC50 is defined as the time 
required to reach steady state at  EC50. Gallic acid was 
used as reference compound. The average of three meas-
urements were reported as L/(min × mg of extract).
Isolation and culture of human umbilical vein endothelial 
cells
This investigation conforms to the principles outlined 
in the Declaration of Helsinki and counts with approval 
from the Ethics Committee of Universidad de Concep-
ción and the Ethics and Scientific Committee of Chil-
ean National Health System, Concepción division (CEC 
19-05-3, 25-06-2019). Patient written informed consents 
were obtained. HUVECs were isolated by collagenase 
digestion (0.25 mg/mL collagenase Type I from Clostrid-
ium histolyticum, Invitrogen, Carlsbad, CA, USA) as 
previously described [26]. After isolation, cells were cul-
tured (37 °C, 5%  CO2) in M199 (Gibco Life Technologies, 
Grand Island, NY, USA) containing 5 mM d-glucose, 10% 
newborn calf serum, 10% fetal calf serum, 3.2 mM l-glu-
tamine, and 100 U/mL penicillin–streptomycin (pri-
mary culture medium). Cells were used up to passage 
2 and experiments were performed on cells depleted 
of serum (12 h) and later incubated as reported in each 
experiment.
Cell viability assay
To determine the toxicity of extracts, HUVECs were 
seeded in 96-well plate dishes and incubated (24  h) 
in M199 (control) in the absence or presence of  H2O2 
(100  µM), and/or G. tinctoria extract (50, 100, 200 
and 300  μg/L) or vehicle of extract (dimethyl sulfox-
ide, DMSO). The sample labels were chosen according 
to minority components added to the culture medium, 
thus cells incubated only with M199 were labeled as con-
trol, those incubated in presence of  H2O2 as  H2O2, those 
incubated in presence of DMSO (1% v/v) as vehicle and 
those incubated in presence of G. tinctoria extract as G. 
tinctoria. After the treatments, cytoxicity was evaluated 
by Alamar Blue (resazurin) assay (Thermo Fisher Scien-
tific, Waltham, MA, USA) incubated at 10% v/v by 2  h 
(37 °C). Fluorescence was measured at 590 nm emission 
using Synergy 2 (Biotek, Winooski, VT, USA) microplate 
reader after 570 nm excitation. Data were expressed as a 
percentage of change in relative fluorescence units (RFU) 
compared to the average of the control.
Live cell imaging
HUVECs were seeded in 6-well plate dishes and incu-
bated (24 h) in M199 in the absence (labeled as control) 
or presence of 25 mM d-glucose (high d-glucose),  H2O2 
(100 µM) and/or G. tinctoria extract (200 μg/L) or vehicle 
(DMSO, 1% v/v). The sample labels were also chosen 
according to minority components added to the culture 
medium, thus those incubated in presence of 25  mM 
d-glucose were labeled as HG, those incubated in pres-
ence of 25  mM d-glucose and of G. tinctoria extract as 
HG+G. tinctoria, and those in presence of hydrogen per-
oxide and of G. tinctoria extract as  H2O2+G. tinctoria. 
Imaging was performed using a Nikon Eclipse Ti-U cou-
pled to a Nikon DS-QiMc camera (Nikon Instruments 
Inc., Melville, USA). Images were created by capturing 
phase contrast with a 40× lens. The apoptotic-like cells in 
each field were quantified and the rate of apoptotic-like 
cells was expressed in relation to the total number of cells 
in each field.
Gene expression of apoptotic gene Noxa
To determine the expression of phorbol-12-myristate-
13-acetate -induced protein 1 (Noxa), total RNA was iso-
lated by chomczynski-fenol method [17] from HUVECs 
incubated in absence (control) or presence of high 
d-glucose (25 mmol/L, 24 h),  H2O2 (100 µM) and/or G. 
tinctoria extract (200  µg/L) or vehicle (DMSO, 1% v/v). 
Non-quantitative polymerase chain reaction (PCR) was 
performed using Swift Max Pro thermal cycler (Esco 
technologies, Horsham, USA) in a reaction mixture con-
taining 0.5  μmol/L primers, deoxynucleotide triphos-
phates, thermostable deoxyribonucleic acid polymerase 
and a reaction buffer (SapphireAmp Fast PCR Master 
Mix, Clontech laboratories, Mountain View, USA). The 
oligonucleotide primers for Noxa were gently provided 
by Dr. Roxana Pincheira (University of Concepción) and 
28S was used as housekeeping. The amplicon images 
(PCR bands) in agarose gel were captured under ultra-
violet (UV) light, documented and analyzed using ImageJ 
software (Java-based imaging processing program, 
National Institute of Health, USA) [17].
Intracellular ROS levels
HUVECs were grown in 24-well plates and incubated 
in absence (control) or presence of high d-glucose 
(25  mmol/L, 24  h),  H2O2 (100  µM) and/or G. tinctoria 
extract (200 μg/L) or vehicle (DMSO, 1% v/v). After treat-
ments, cells were exposed (45 min, 37 °C) to 10 μmol/L of 
CM-H2DCFDA (Molecular Probes, Leiden, The Nether-
lands) in phosphate buffered saline (37  °C, pH 7.4). The 
fluorescence of CM-H2DCFDA (λexc/λem: 495/510 nm) 
was determined in a Synergy 2 (Biotek, Winooski, VT, 
USA) microplate reader [17].
Intracellular NO levels
HUVECs were grown on microscope coverslips and incu-
bated with M199 (labeled as Control), G. tinctoria extract 
(200 μg/L) (labeled as G. tinctoria), ellagic acid-enriched 
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fraction (labeled as F3) or DMSO (labeled as vehicle, 1% 
v/v). To determine intracellular NO, cells were loaded 
(45 min, 37 °C) with 10 μM of 4-amino-5-methylamino-
2′,7′-difluorofluorescein (DAF-FM) (Molecular Probes, 
Leiden, The Netherlands). The fluorescence was deter-
mined in fixed cells and the signal density was analyzed 
by ImageJ software (Java-based imaging processing pro-
gram, National Institute of Health, USA) [25]. Histamine 
(10 μM, 5 min) was used as positive control [27].
Wire myography in placental veins
Human placental veins of 2–3  mm external diam-
eter were isolated, freed of adhering connective tissue, 
and cut into 2-mm ring segments. Two stainless steel 
wires were inserted through the vessel ring, one con-
nected to a Grass FT03 force displacement transducer 
for isometric recording of the contractions on a Grass 
recorder (Model 79 D), and the other was used to adjust 
the resting tension vessels to 1.0 g. Vessels were bathed 
in modified Krebs–Ringer solution [mM: 119 NaCl, 4.6 
KCl, 15  NaHCO3, 1.5  CaCl2, 1.2  MgCl2, 1.2  NaH2PO4, 
5 d-glucose (pH 7.4, 37  °C, 95%  O2/5%  CO2)]. After the 
optimal resting tension was obtained, the tissues were 
allowed to equilibrate for 1 h. At the beginning and end 
of each experiment, the maximal contractile response to 
90 mM KCl solution was recorded. Only if the contractile 
responses were similar in magnitude (with variation less 
than 10%), the data from this particular experiment were 
included in the analysis [28]. After maximal response to 
KCl, vessels were washed and equilibrated for 30–40 min. 
Vessels were incubated with U46619 (0.1 µM, thrombox-
ane A2 analog) and after 5 min 200 μg/L of G. tinctoria 
extract were added in the experimental group. Changes 
in isometric tension were registered for 15 min following 
incubation with the extract.
Statistical analysis
The data of FRAP assay were analyzed with a one-way 
analysis of variance at the 95% confidence level. Differ-
ences among the mean values of antioxidant power at 
4 and 60 min were determined with Duncan’s multiple-
range test.
In endothelial cell and vascular reactivity assays, the 
values are mean ± S.E.M., where n indicates the number 
of different biological samples in triplicated. Compari-
sons between two groups were performed by means of 
Student’s unpaired t-test or Mann–Whitney test for para-
metric or non-parametric data, respectively. The statis-
tical software GraphPad Prism 6.0 (GraphPad Software 
Inc., San Diego, CA, USA) was used for data analysis; 
p < 0.05 was considered statistically significant.
Results
Polyphenol content and composition of G. tinctoria extract
The methanolic extract of G. tinctoria leaf showed a high 
polyphenol content of 520 ± 30  mg GAE/g dry extract. 
The HPLC–UV profile of the extract (Fig.  1a), revealed 
the presence of 10 compounds with a prominent peak 
of ellagic acid. Its concentration determined by HPLC 
was 166 ± 2 mg/g dry extract. After the pH zone refine-
ment separation (Fig. 1b), four fractions (F1, F2, F3 and 
F4) were gathered and analyzed by LC–MS. This strat-
egy allowed the enrichment of minor phenolic com-
pounds of the extract for the tentative identification by 
High-Resolution Q-Orbitrap MS. The retention times 
presented in Table 1 differed from those obtained in the 
HPLC system with a monolithic column used for ellagic 
acid rapid quantification. UHPLC uses a smaller par-
ticle size to improve resolution. The identity of 9 com-
pounds could be confirmed, being ellagic acid the main 
constituent. The latter could be obtained in one-step fast 
purification in F3 using pH-zone refinement in the Spot-
CPC-250-Bio-Extractor device (Fig.  1b). Other minor 
phenolic derivatives can also be purified using this pre-
parative tool (Fig. 1b and Table 1).
In vitro antioxidant activity of methanolic extract of G. 
tinctoria
The ferric reducing antioxidant power assay is associated 
to the reduction of ferric 2,4,6-tripyridyl-s-triazine com-
plex [Fe(III)] to ferrous 2,4,6-tripyridyl-s-triazine com-
plex [Fe(II)]. The FRAP values for the methanolic extract 
and quercetin at 4 and 60 min are shown in Table 2. The 
FRAP value for the G. tinctoria extract at 60  min was 
higher than that at 4  min, and lower (almost half ) than 
those obtained for the quercetin standard, a flavonoid 
with high antioxidant power [29].
The radical scavenging capacity of the extract was 
determined as the percentage of remaining DPPH as a 
function of the extract concentration. The percentage of 
remaining DPPH decreased with increasing extract con-
centration. The compounds present in methanolic extract 
at 5  µg/mL, minimum dose tested, reduced the DPPH 
by 40% (Table 3). The antiradical efficiency of the extract 
was 2.03 × 10−4 L/mg × min; being of the same order of 
magnitude as the reported for gallic acid (8.51 × 10−4), 
a monophenolic compound with medium antioxidant 
power [30].
Effects of G. tinctoria extract on endothelial cells 
monolayer
No significant difference in cell viability was found in 
the incubated HUVECs (24 h) with different G. tinctoria 
extract concentrations (50, 100, 200 and 300 μg/L) com-
pared with the control or vehicle (Fig. 2).
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Fig. 1 a HPLC profile of G. tinctoria extract using a monolithic RP‑18 column. b pH‑zone refinement in CPC apparatus of G. tinctoria extract. Peak 
number are the same of Table 1
Table 1 Identification of polyphenol compounds detected in methanolic extract from G. tinctoria leaves by UHPLC-DAD-
HR-Q-Orbitrap MS
Peak # (Fraction) UV max Tentative identification Molecular formula Retention 
time (min)
Measured mass (m/z) MSn ions
1 (F1) 310 p‑Coumaroyl glucoside C15H17O8 9.78 325.09649 –
2 (F1) 325 Digalloylglucose C20H17O14 9.57 483.07800 –
3 (F1) 256–353 Rutin C27H29O16 10.32 609.14611 301.03512
4 (F2) 254–354 Quercetin‑3‑O‑rhamnoside C21H20O11 10.63 447.09316 –
5 (F2) 325 Potentilline C41H27O26 11.55 935.07501 300.99906
6 (F2) 325 Tellimagrandin C41H29O26 12.23 937.08966 300.99908
7 (F3) 282, 326 (shoulder) Ellagic acid C14H5O8 12.43 300.99855 284.2; 229.3; 185.2
8 (F4) 324 Caffeic acid C9H7O4 12.83 179.03441 –
9 (F4) 325 Chebulagic acid C41H29O27 13.22 953.09017 300.99856
10 (F4) 255–275 Unknown C11H11O6 13.53 239.0560 –
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Figure  3 shows that the incubation with G. tinctoria 
extract did not disrupt the HUVECs monolayer. Apoptotic 
morphology was also not evidenced in HUVECs treated 
with the extract. The qualitative analysis of cell morphology 
showed that high d-glucose and  H2O2 induced cell shrink-
age, membrane blebbing and formation of apoptotic bod-
ies. These characteristics were not observed in cell cultures 
co-incubated with the G. tinctoria extract (Fig.  3e). The 
vehicle (DMSO) did not induce significative changes in the 
morphology of HUVECs (Fig.  3d). As an example, apop-
totic cells are indicated by black arrows in the Fig. 3. The 
rate of apoptotic-like cells was increased 3.2-fold and 4.0-
fold by high d-glucose and  H2O2, respectively (Fig. 3b and 
c). The co-incubation with G. tinctoria extract prevented 
the apoptosis induced by high d-glucose and  H2O2 and the 
rate of apoptotic-like cells returned to levels similar to the 
control or vehicle (Fig. 3f and g).
Apoptosis was also determined by expression of Noxa. 
Figure 4a shows a representative image of the PCR prod-
ucts. In cells incubated with high d-glucose or  H2O2, the 
Noxa expression was increased 9.3-fold and 8.0-fold com-
pared with the control, respectively. Co-incubation with G. 
tinctoria extract suppressed the effects of high d-glucose 
and  H2O2 on Noxa mRNA levels (Fig. 4b).
Antioxidant effect of G. tinctoria extract on endothelial 
cells
The G. tinctoria extract decreased the ROS content by 50% 
compared to control. The equivalent concentration (v/v) of 
vehicle did not influence the ROS production. High d-glu-
cose or  H2O2 increased the ROS level compared to control 
5-fold and 1.9-fold, respectively. The co-incubation with G. 
tinctoria extract blocked the ROS production induced by 
high d-glucose and  H2O2 (Fig. 5).
Effect of G. tinctoria extract on NO levels
Enhanced DAF fluorescence in cytoplasm of cells was 
observed in HUVECs incubated with the G. tinctoria 
extract or an ellagic acid-enriched fraction (F3). Fluores-
cence in cells incubated with G. tinctoria extract was more 
intense than fluorescence in cells incubated with histamine, 
but fluorescence distribution was similar in both (Fig.  6). 
Quantification of fluorescence intensity revealed that the 
G. tinctoria extract and the ellagic acid-enriched fraction 
(F3) increased NO levels 2.2-fold in HUVECs, compared 
with the control or vehicle.
Table 2 Ferric reducing antioxidant power values of  G. 
tinctoria extract at 4 and 60 min
Data are shown as mean ± standard deviation (n = 3)
Values in the same column with different superscripts letters (a, b) are 
significantly different (p < 0.05) according to Duncan’s Multiple Range Test
Sample µmol of  Fe2+/g of extract 
or standard
4 min 60 min
G. tinctoria extract 0.73 ± 0.01a 1.44 ± 0.02a
Quercetin 1.88 ± 0.02b 3.01 ± 0.14b
Table 3 DPPH radical scavenging activity of  G. tinctoria 
extract
Data are shown as mean ± standard deviation (n = 3)
EC50: The antioxidant concentration that decreased by 50% the DPPH radical, 
estimated at steady state
TEC50: Time taking to reach steady state at EC50
Sample EC50 (mg/L) TEC50 (min)
G. tinctoria extract 178 ± 12 28 ± 3
Gallic acid 50.06 ± 0.01 24 ± 2
Fig. 2 Effect of G. tinctoria extract on cell viability. Cell viability was 
determined in HUVECs incubated (24 h) with M199 in absence 
(control) or presence of  H2O2 (100 μM), DMSO (extract vehicle) or 
different concentrations of G. tinctoria extract (50–300 μg/L). After 
treatments, cytotoxicity was evaluated by Alamar Blue (resazurin) 
assay. Cell viability was expressed as percentage (%) of mean 
fluorescence in control. Values are mean ± SEM, n = 4. *p < 0.05 versus 
control
Fig. 3 Effect of G. tinctoria extract on apoptotic‑like cell death induced by high d‑glucose and hydrogen peroxide. Representative images of light 
microscopy of HUVECs (×40) incubated (24 h) in M199, in absence (control) (a–d) or presence of 200 μg/L of G. tinctoria extract (G. tinctoria) (e–g). 
Cells were co‑incubated in presence of 25 mM d‑glucose (HG) (b, f), 100 µM  H2O2 (c, g) or extract, vehicle (DMSO) (d). Black arrows in B indicate 
examples of apoptotic‑like HUVECs. Apoptotic‑like HUVECs were quantified in images from different fields (three experiments in duplicate) and 
result was expressed as rate of apoptotic‑like cells in total cells in each field (h). Values are mean ± SEM, n = 3. **p < 0.01 versus control or vehicle; 
***p < 0.005 versus control or vehicle; Фp < 0.05 versus high d‑glucose; γp < 0.05 versus  H2O2
(See figure on next page.)
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Fig. 4 Effect of G. tinctoria on apoptotic gene Noxa, induced by high d‑glucose and hydrogen peroxide. a Representative images of PCR products 
of Noxa and 28S obtained from HUVECs incubated with M199 and: 25 mM d‑glucose (HG) or  H2O2 in absence or presence of 200 μg/L of G. tinctoria 
extract (labeled as HG+G. tinctoria or  H2O2 + G. tinctoria, respectively). b The intensity of amplicon images from three different experiments were 
analyzed and rate between Noxa and 28S was plotted to represent the effect of G. tinctoria on changes in Noxa expression in HUVECs. Values are 
mean ± SEM, n = 3. *p < 0.05 versus control or vehicle; **p < 0.01 versus control or vehicle; Фp < 0.05 versus high d‑glucose; γp < 0.05 versus  H2O2
Effect of G. tinctoria extract on contractile response 
of human placental veins
The increase of constriction induced by thrombox-
ane A2 analog, U46619, was significantly reduced by 
200 μg/L G. tinctoria extract (Fig. 7).
In summary, the presence of apoptotic endothelial 
cells induced by high levels of d-glucose or  H2O2 was 
significantly reduced by co-incubation of HUVECs with 
G. tinctoria extract, which is confirmed by the blocking 
of Noxa expression. The ability of the extract to reduce 
high d-glucose- and  H2O2-induced ROS is congruent 
with the reduction of U46619- induced vasoconstric-
tion and the stimulation of NO synthesis.
Discussion
Gunnera tinctoria is commonly harvested for its edible 
petiole. Their leaves and roots are also used for food 
and medicinal purposes. The beneficial effects of its 
leaves are attributed to their high polyphenol content. 
We found gallic acid equivalents of 520  mg/g extract, 
where almost 32% of the leaf extract was ellagic acid. 
The reported polyphenol content of a methanolic 
extract of Gunnera perpensa, another species of the 
genus Gunnera, was much lower (248.45  mg GAE/g 
extract) compared with the values found by us for the 
G. tinctoria leaf extract [31].
Ellagic acid, the main constituent of the G. tinctoria 
extract, with four phenolic and two lactone groups, can 
act as hydrogen bond donor and acceptor which makes it 
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a powerful antioxidant [32]. Several phenolic compounds 
in extracts of Gunnera genus have been identified. Fif-
teen flavonoids (glycosides of quercetin, kaempferol and 
isorhamnetin) have been isolated from leaves of endemic 
Gunnera species grown in Juan Fernández island, Chile: 
G. bracteata, G. masafuerae and G. peltata [33]. The 
authors found that glycosides of isorhamnetin are flavo-
noids characteristic of these species of Gunnera genus. 
G. tinctoria is considered a likely progenitor for endemic 
species of Juan Fernandez, according to morphological 
and flavonoid data. In other species of Gunnera genus 
such as G. densiflora, pelargonidin 3,5-diglucoside is the 
main polyphenol found in leaf extracts [34]. Gallic acid 
is also identified as a predominant phenol in aqueous 
and methanolic extracts of leaves of Brazilian G. Mani-
cata [35]. Ellagic acid and its derivatives have been iden-
tified only in G. perpensa. The glucoside of ellagic acid, 
trimethyl ether, 4-O-β-d-glucopyranosyl-3,3′,4′-tri-O-
methyl-ellagic acid, was isolated from aqueous extract of 
G. perpensa roots [36]. Mayori et al. [37] reported other 
phenolic lactones isolated from methanolic extracts 
of G. perpensa root, such as ellagic acid and 3,3′,4-tri-
O-methyl ellagic acid. Mammo et al. [38] also described 
the presence of another glucoside of ellagic acid isolated 
from G. perpensa, punicalagin. However, ellagic acid or 
its derivatives are not reported as majority compounds in 
G. perpensa species. Note that ellagic acid is considered 
a strong antioxidant, capable of scavenging free radicals 
such as hydroxyl, peroxyl,  NO2 and peroxynitrite [39].
FRAP and DPPH results for methanolic extracts con-
firm their antioxidant activity by inhibition pathway of 
radical species. The methanolic extracts of roots, rhi-
zomes and bulbs of G. perpensa also reduce DPPH radi-
cals [32, 40]. The antioxidant response of these extracts 
is related to the content and chemical structure of poly-
phenols, and their interactions with other antioxidants. 
In general, plant extracts with free ellagic acid and ellagi-
tannins have a higher antioxidant activity [8]. The strong 
activity of Punica granatum L. juice is attributed to its 
polyphenols, including punicalagin and ellagic acid [41]. 
However, P. granatum juice and juice extract showed 
superior antioxidant activity compared to its purified 
polyphenols. Therefore, the antioxidant effect is not only 
attributed to polyphenolic compounds, but also to terpe-
noids and steroids [42, 43].
In the case of the G. tinctoria extract, we found no dif-
ference in NO levels between the application of the crude 
extract or the enriched fraction in ellagic acid (F3). It has 
been found that ellagic acid is a compound with proven 
properties in the prevention of endothelial dysfunction 
associated with atherosclerosis and inflammation. Thus, 
Lee et al. [10] showed that the pre-treatment of HUVECs 
with ellagic acid (5–20  µM) followed by exposure to 
oxLDL inhibits the expression of lectin-like receptor 
for oxLDL (LOX-1). The decrease of LOX-1 induced by 
ellagic acid attenuates the NADPH oxidase abundance 
in the endothelial cell membrane, which results in the 
decrease of intracellular ROS formation. The incubation 
with ellagic acid also restores the endothelial nitric oxide 
synthase expression decreased by oxLDL. Mele et al. [44] 
found that the treatment of HUVECs with ellagic acid 
(5–10 µM, 6 h) decreases the monocyte adhesion, the sol-
uble vascular cell adhesion molecule-1 and interleukin-6 
secretion, induced by tumor necrosis factor-α.
G. tinctoria extract delays ROS production in 
endothelial cells induced by high d-glucose (25  mM), 
a stimulus that increases the synthesis of superoxide 
through activation of NADPH oxidase in HUVECs 
[17]. Considering that incubation with ellagic acid 
(20 µM) prevents the increase of ROS induced by high 
d-glucose (30  mM) in human aortic endothelial cells 
[45], a potential mechanism for the antioxidant effect 
of G. tinctoria extracts could be related to the regula-
tion of expression and activity of  NADPH oxidase by 
ellagic acid. NADPH oxidase is the main source of ROS 
in the endothelium [17], so the down-regulation of its 
expression in hyperglycemia is a key mechanism for 
improving endothelial function. The incubation with 
ellagic acid also induces endothelium-dependent vaso-
dilation in rat aortic rings [46], which could be related 
Fig. 5 Effect of G. tinctoria extract on oxidative stress induced by 
high d‑glucose and hydrogen peroxide. Reactive Oxygen Species 
(ROS) levels were determined by 2′,7′‑dichlorofluorescein fluorescent 
probe in HUVECs incubated with M199 and 25 mM d‑glucose (HD) 
or M199 and 100 μM  H2O2 in absence or presence of 200 μg/L of G. 
tinctoria extract (labeled as HG + G. tinctoria or  H2O2+G. tinctoria, 
respectively). Changes in ROS levels are shown as rate of control. 
Values are mean ± SEM, n = 3. *p < 0.05 versus vehicle, Фp < 0.05 
versus high d‑glucose; γp < 0.05 versus  H2O2
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to the reduction in U46619-induced constriction by 
the G. tinctoria extract. Previously, it has been deter-
mined that endothelial-protective stimuli, like insulin, 
decreases the constriction induced by U46619 in pla-
cental veins, by a mechanism dependent on endothe-
lium-derived NO [47]. Further studies are required to 
determine whether the effects of the G. tinctoria extract 
on NO synthesis or vascular reactivity depend on NOS 
activity. For example, by co-incubation of the extract 
with N(ω)-nitro-l-arginine methyl ester and endothe-
lium denudation in vascular reactivity assays.
Fig. 6 Effect of F3 fraction of G. tinctoria extract and crude extract on nitric oxide levels. Nitric oxide (NO) levels were determined with DAF through 
fluorescence microscopy in HUVECs incubated (37 °C, 24 h) with M199 in absence (Control) (c) or presence of 200 μg/L of G. tinctoria extract 
(labeled as G. tinctoria) (a), 200 μg/L of ellagic acid‑enriched fraction (labeled as F3) (b) or vehicle (d). Positive control were cells incubated (37 °C, 
5 min) with 10 μM histamine (labeled histamine) (e). In images, green fluorescence corresponds to DAF probe and blue fluorescence corresponds 
to 4′,6‑diamidino‑2‑phenylindole, for nuclei staining. The density of DAF fluorescence per cell was quantify using ImageJ software and was 
expressed as rate of control (f). Values were expressed as mean ± SE, n = 3. *p < 0.05 versus Control; Фp < 0.05 versus vehicle. The scale bar represents 
50 μm
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The G. tinctoria extract showed an anti-apoptotic effect 
associated with regulation of Noxa expression. In addi-
tion, it has been determined, that homocysteine, a mole-
cule related to endothelial dysfunction and cardiovascular 
disease [48], increases the Noxa expression in HUVECs. 
This effect is blocked by the NO donor S-nitroso-N-
acetylpenicillamine [49]. This evidence suggests that the 
mechanism involved in the regulation of Noxa expres-
sion and apoptosis by the extract could be related to 
the increase of induced NO. Thus, the mechanism for 
vascular actions of the extract could involve the activity 
of ellagic acid on a signaling pathway that decreases the 
NADPH oxidase-derived ROS and increases the activity 
of endothelial NOS, improving the endothelium-derived 
NO availability.
Conclusion
This study provides scientific evidence on the ethnome-
dicinal use of G. tinctoria leaves in Chilean folk medi-
cine. The methanolic G. tinctoria extract has a positive 
effect on endothelial function in pathophysiological 
conditions of high d-glucose and  H2O2: it increases NO 
synthesis, reduces ROS levels and inhibits the apopto-
sis in HUVECs. The improved endothelial function and 
antioxidant activity of the extract suggests its potential 
application in the formulation of phytomedicines for 
the treatment of a wide range of diseases.
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